Form Type: 4

SEC EDGAR Link
Accession Number:0001437749-22-014039
Date:2022-05-31
Issuer: NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)
Original Submission Date:

Reporting Person:

BHALLA AMIT
4995 BRADENTON AVE., SUITE 240
DUBLIN, OH 43017

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-05-31 A 2,500 a $0.00 58,068 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 stock issued under the amended and restated 2014 stock incentive plan in partial payment of monthly non-employee director fees.
f2 issuance deferred at the request of the reporting person.
WhaleWisdom Logo

Elevate your investments